209 related articles for article (PubMed ID: 3925247)
1. Factor VIII-von Willebrand factor in giant cell arteritis and polymyalgia rheumatica.
Persellin ST; Daniels TM; Rings LJ; Kazmier FJ; Bowie EJ; Hunder GG
Mayo Clin Proc; 1985 Jul; 60(7):457-62. PubMed ID: 3925247
[TBL] [Abstract][Full Text] [Related]
2. Elevation of von Willebrand factor is independent of erythrocyte sedimentation rate and persists after glucocorticoid treatment in giant cell arteritis.
Federici AB; Fox RI; Espinoza LR; Zimmerman TS
Arthritis Rheum; 1984 Sep; 27(9):1046-9. PubMed ID: 6332630
[TBL] [Abstract][Full Text] [Related]
3. Von Willebrand factor in the outcome of temporal arteritis.
Cid MC; Monteagudo J; Oristrell J; Vilaseca J; Pallarés L; Cervera R; Font C; Font J; Ingelmo M; Urbano-Márquez A
Ann Rheum Dis; 1996 Dec; 55(12):927-30. PubMed ID: 9014589
[TBL] [Abstract][Full Text] [Related]
4. [Comparative study of von Willebrand factor in patients with temporal arteritis].
González-Gay MA; Alvarez MD; Machín AJ; Alonso MD; García González J; Cereijo MJ; Bal M
An Med Interna; 1992 Oct; 9(10):483-6. PubMed ID: 1420759
[TBL] [Abstract][Full Text] [Related]
5. Von Willebrand factor in polymyalgia rheumatica and giant cell arteritis.
Uddhammar AC
Clin Exp Rheumatol; 2000; 18(4 Suppl 20):S32-3. PubMed ID: 10948757
[TBL] [Abstract][Full Text] [Related]
6. Plasma levels of fibronectin in polymyalgia rheumatica giant cell arteritis.
Puccetti L; Marotta G; Remorini E; Lucchetti A; Zuccotti M; Petrini G; Baicchi U; Ciompi ML
Rheumatol Int; 1987; 7(6):249-54. PubMed ID: 3125593
[TBL] [Abstract][Full Text] [Related]
7. Electrophoretic heterogeneity of normal factor VIII/Von Willebrand protein, and abnormal electrophoretic mobility in patients with Von Willebrand's disease.
Sultan Y; Simeon J; Caen JP
J Lab Clin Med; 1976 Feb; 87(2):185-94. PubMed ID: 1082003
[TBL] [Abstract][Full Text] [Related]
8. Serological and immunohistochemical determination of von Willebrand factor antigen in serum and biopsy specimens from patients with arteritis temporalis and polymyalgia rheumatica.
Olsson A; Elling P; Elling H
Clin Exp Rheumatol; 1990; 8(1):55-8. PubMed ID: 2189625
[TBL] [Abstract][Full Text] [Related]
9. Serum immunoglobulin G4 in giant cell arteritis and polymyalgia rheumatica.
Burkel M; Arndt F; Schirmer JH; Moosig F; Holle JU
Clin Exp Rheumatol; 2017; 35 Suppl 103(1):94-97. PubMed ID: 27974093
[TBL] [Abstract][Full Text] [Related]
10. Behaviour of von Willebrand factor antigen in follow-up of polymyalgia rheumatica/giant cell arteritis.
Ciompi ML; Marotta G; Puccetti L; Remorini E; Petrini G; Zuccotti M; Vispi M; Baicchi U; Iacconi P
Scand J Rheumatol; 1988; 17(6):491-5. PubMed ID: 3266032
[No Abstract] [Full Text] [Related]
11. Microheterogeneity of alpha 1-antichymotrypsin in the management of giant-cell arteritis and polymyalgia rheumatica.
Hachulla E; Laine A; Hayem A
Clin Sci (Lond); 1990 Jun; 78(6):557-64. PubMed ID: 2165887
[TBL] [Abstract][Full Text] [Related]
12. Antibodies to cardiolipin and beta 2 glycoprotein I in patients with polymyalgia rheumatica and giant cell arteritis.
Meyer O; Nicaise P; Moreau S; de Bandt M; Palazzo E; Hayem G; Chazerain P; Labarre C; Kahn MF
Rev Rhum Engl Ed; 1996 Apr; 63(4):241-7. PubMed ID: 8738442
[TBL] [Abstract][Full Text] [Related]
13. Lack of von Willebrand factor, factor VIII related antigen and factor VIII coagulant response to human growth hormone infusion in type 2 diabetes mellitus.
Grecu EO; Sheikholislam BM; Abildgaard CF
Am J Med Sci; 1984; 287(2):3-6. PubMed ID: 6424471
[TBL] [Abstract][Full Text] [Related]
14. [Factor VIII (coagulation activity VIII:C, antigen concentration VIIIR:Ag and von Willebrand factor) in patients with clinically expected intravascular coagulation].
Tran TH; Lämmle B; Marbet UA; Ritz R; Marbet GA; Duckert F
Schweiz Med Wochenschr; 1981 Oct; 111(41):1542-3. PubMed ID: 6797063
[TBL] [Abstract][Full Text] [Related]
15. Plasminogen activator inhibitor and von Willebrand factor in polymyalgia rheumatica.
Uddhammar A; Rantapåå-Dahlqvist S; Nilsson TK
Clin Rheumatol; 1992 Jun; 11(2):211-5. PubMed ID: 1617895
[TBL] [Abstract][Full Text] [Related]
16. Variant von Willebrand's disease: characterization of two subtypes by analysis of multimeric composition of factor VIII/von Willebrand factor in plasma and platelets.
Ruggeri ZM; Zimmerman TS
J Clin Invest; 1980 Jun; 65(6):1318-25. PubMed ID: 6773982
[TBL] [Abstract][Full Text] [Related]
17. Platelet von Willebrand factor: comparison with plasma von Willebrand factor.
Gralnick HR; Williams SB; McKeown LP; Krizek DM; Shafer BC; Rick ME
Thromb Res; 1985 Jun; 38(6):623-33. PubMed ID: 3927508
[TBL] [Abstract][Full Text] [Related]
18. Plasma adrenomedullin levels in patients with polymyalgia rheumatica and giant cell arteritis.
Garcia-Unzueta MT; Martínez-Taboada VM; Amado-Señarís JA; Rodríguez-Valverde V
Clin Exp Rheumatol; 2006; 24(2 Suppl 41):S6-9. PubMed ID: 16859588
[TBL] [Abstract][Full Text] [Related]
19. Elevated von Willebrand factor antigen in systemic sclerosis: relationship to visceral disease.
Greaves M; Malia RG; Milford Ward A; Moult J; Holt CM; Lindsey N; Hughes P; Goodfield M; Rowell NR
Br J Rheumatol; 1988 Aug; 27(4):281-5. PubMed ID: 3136816
[TBL] [Abstract][Full Text] [Related]
20. Giant-cell arteritis. Histological, immunohistochemical and electronmicroscopic studies.
Chemnitz J; Christensen BC; Christoffersen P; Garbarsch C; Hansen TM; Lorenzen I
Acta Pathol Microbiol Immunol Scand A; 1987 Sep; 95(5):251-62. PubMed ID: 2442962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
